Literature DB >> 18615174

Case report of olanzapine-associated elevation of serum creatine kinase in a 16-year-old boy with heat stroke.

Mohammad Jafferany, Jennifer Lowry.   

Abstract

Entities:  

Year:  2008        PMID： 18615174      PMCID： PMC2446495          DOI： 10.4088/pcc.v10n0312c

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  12 in total

1.  Antipsychotic drugs, serum creatine kinase (CPK) and possible mechanisms.

Authors:  S Devarajan; S M Dursun
Journal:  Psychopharmacology (Berl)       Date:  2000-09       Impact factor: 4.530

2.  Massive increase in serum creatine kinase during olanzapine and quetiapine treatment, not during treatment with clozapine.

Authors:  E Boot; L de Haan
Journal:  Psychopharmacology (Berl)       Date:  2000-06       Impact factor: 4.530

3.  Olanzapine elevation of serum creatine kinase.

Authors:  Ezequiel Martí-Bonmatí; Eva San Valero-Carcelén; María Pilar Ortega-García; Ricardo Rubini-Puig
Journal:  J Clin Psychiatry       Date:  2003-04       Impact factor: 4.384

Review 4.  Sympathoadrenal hyperactivity and the etiology of neuroleptic malignant syndrome.

Authors:  R J Gurrera
Journal:  Am J Psychiatry       Date:  1999-02       Impact factor: 18.112

5.  Serum creatine kinase levels in chronic psychosis patients--a comparison between atypical and conventional antipsychotics.

Authors:  Kristina Melkersson
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-06-23       Impact factor: 5.067

6.  Skeletal muscle necrosis following membrane-active drugs plus serotonin.

Authors:  H Y Meltzer
Journal:  J Neurol Sci       Date:  1976-05       Impact factor: 3.181

7.  Incipient neuroleptic malignant syndrome?

Authors:  V R Velamoor; M L Fernando; P Williamson
Journal:  Br J Psychiatry       Date:  1990-04       Impact factor: 9.319

8.  Massive creatine kinase elevations with quetiapine: report of two cases.

Authors:  J P Klein; U Fiedler; H Appel; A Quante; M C Jockers-Scherübl
Journal:  Pharmacopsychiatry       Date:  2006-01       Impact factor: 5.788

9.  Marked elevation of serum creatine kinase associated with olanzapine therapy.

Authors:  E L Marcus; A Vass; J Zislin
Journal:  Ann Pharmacother       Date:  1999-06       Impact factor: 3.154

10.  Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome.

Authors:  Joseph W Y Lee
Journal:  Ann Clin Psychiatry       Date:  2007 Jan-Mar       Impact factor: 1.567
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.